Fénichel Patrick, Chevalier Nicolas, Lahlou Najiba, Coquillard Patrick, Wagner-Mahler Kathy, Pugeat Michel, Panaïa-Ferrari Patricia, Brucker-Davis Françoise
Department of Reproductive Endocrinology, University Hospital of Nice, Nice, France.
Institut National de la Recherche Médicale, UMR U1065, Université Nice-Sophia Antipolis, Nice, France.
Front Endocrinol (Lausanne). 2019 Jan 10;9:786. doi: 10.3389/fendo.2018.00786. eCollection 2018.
Cryptorchidism, a frequent genital malformation in male newborn, remains in most cases idiopathic. On the basis of experimental, epidemiological, and clinical data, it has been included in the testicular dysgenesis syndrome and believed to be influenced, together with genetic and anatomic factors, by maternal exposure to endocrine disrupting chemicals (EDCs). Here, we analyze how EDCs may interfere with the control of testicular descent, which is regulated by two Leydig cell hormones, testosterone, and insulin like peptide 3 (INSL3).
隐睾症是男性新生儿常见的生殖器畸形,在大多数情况下仍病因不明。基于实验、流行病学和临床数据,它已被纳入睾丸发育不全综合征,并且被认为与遗传和解剖因素一起,受到母体接触内分泌干扰化学物质(EDCs)的影响。在此,我们分析了EDCs可能如何干扰睾丸下降的控制,而睾丸下降是由两种睾丸间质细胞激素——睾酮和胰岛素样肽3(INSL3)调节的。